Display options
Share it on

Cells. 2021 Dec 25;11(1). doi: 10.3390/cells11010057.

TRAIL Triggers CRAC-Dependent Calcium Influx and Apoptosis through the Recruitment of Autophagy Proteins to Death-Inducing Signaling Complex.

Cells

Kelly Airiau, Pierre Vacher, Olivier Micheau, Valerie Prouzet-Mauleon, Guido Kroemer, Mohammad Amin Moosavi, Mojgan Djavaheri-Mergny

Affiliations

  1. Institut Bergonié, INSERM U1218, University of Bordeaux, 33000 Bordeaux, France.
  2. Lipides, Nutrition Cancer, INSERM, UMR1231, 21079 Dijon, France.
  3. UFR Science de Santé, Université de Bourgogne, Franche-Comté, 21079 Dijon, France.
  4. Centre de Recherche des Cordeliers, INSERM UMRS 1138, Sorbonne Université, Université de Paris, Equipe 11 Labellisée par la Ligue Contre le Cancer, 75006 Paris, France.
  5. Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.
  6. Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, 75015 Paris, France.
  7. Department of Molecular Medicine, National Institute of Genetic Engineering and Biotechnology, Tehran P.O. Box 14965/161, Iran.

PMID: 35011619 PMCID: PMC8750441 DOI: 10.3390/cells11010057

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively kills various cancer cell types, but also leads to the activation of signaling pathways that favor resistance to cell death. Here, we investigated the as yet unknown roles of calcium signaling and autophagy regulatory proteins during TRAIL-induced cell death in leukemia cells. Taking advantage of the Gene Expression Profiling Interactive Analysis (GEPIA) project, we first found that leukemia patients present a unique TRAIL receptor gene expression pattern that may reflect their resistance to TRAIL. The exposure of NB4 acute promyelocytic leukemia cells to TRAIL induces intracellular Ca

Keywords: ATG7; ATRA; CRAC channels; DISC; ORAI1; autophagy; cancer; leukemia; p62/SQSTM1; resistance to therapy

References

  1. Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16677-82 - PubMed
  2. EMBO J. 2015 Apr 1;34(7):856-80 - PubMed
  3. Nucleic Acids Res. 2019 Apr 8;47(6):2739-2756 - PubMed
  4. Nat Cell Biol. 2000 Apr;2(4):241-3 - PubMed
  5. Haematologica. 2005 May;90(5):612-24 - PubMed
  6. Br J Cancer. 2006 Feb 13;94(3):398-406 - PubMed
  7. Cells. 2020 Jun 24;9(6): - PubMed
  8. Cell Death Differ. 2021 Feb;28(2):657-670 - PubMed
  9. Genet Mol Res. 2015 Dec 28;14(4):18562-8 - PubMed
  10. Oncotarget. 2013 Sep;4(9):1349-64 - PubMed
  11. Biomed Res Int. 2015;2015:352794 - PubMed
  12. Mol Oncol. 2015 Apr;9(4):806-17 - PubMed
  13. Autophagy. 2011 Oct;7(10):1108-14 - PubMed
  14. Mol Pharmacol. 2006 Apr;69(4):1413-20 - PubMed
  15. J Biol Chem. 2005 May 27;280(21):20722-9 - PubMed
  16. Cell Death Differ. 2004 Mar;11(3):321-30 - PubMed
  17. Cell. 2019 Jan 10;176(1-2):11-42 - PubMed
  18. EMBO Rep. 2013 Feb;14(2):143-51 - PubMed
  19. Int J Mol Sci. 2020 Nov 06;21(21): - PubMed
  20. Cold Spring Harb Perspect Biol. 2013 May 01;5(5):a008698 - PubMed
  21. FEBS J. 2017 Apr;284(8):1131-1159 - PubMed
  22. Cell Death Dis. 2010 Sep 16;1:e75 - PubMed
  23. FEBS J. 2021 Oct;288(19):5530-5554 - PubMed
  24. Autophagy. 2013 Nov 1;9(11):1710-9 - PubMed
  25. Cells. 2021 Nov 30;10(12): - PubMed
  26. Dev Cell. 2016 May 23;37(4):337-349 - PubMed
  27. Cell Mol Biol Lett. 2016 Dec 13;21:29 - PubMed
  28. Nat Med. 1999 Feb;5(2):157-63 - PubMed
  29. Mol Cancer. 2014 Mar 23;13:70 - PubMed
  30. Drug Resist Updat. 2015 Mar;19:13-21 - PubMed
  31. Trends Mol Med. 2004 Oct;10(10):508-15 - PubMed
  32. Biochem Biophys Res Commun. 2015 Apr 24;460(1):114-21 - PubMed
  33. Apoptosis. 2008 Jan;13(1):1-9 - PubMed
  34. Cancers (Basel). 2019 Sep 30;11(10): - PubMed
  35. Cell Death Differ. 2000 May;7(5):447-60 - PubMed
  36. Blood. 1991 Mar 1;77(5):1080-6 - PubMed
  37. Cell. 2003 Jul 25;114(2):181-90 - PubMed
  38. Future Oncol. 2021 Feb;17(5):581-596 - PubMed
  39. Cell Death Differ. 2012 Dec;19(12):2003-14 - PubMed
  40. Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):504-509 - PubMed
  41. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3438-43 - PubMed
  42. Blood. 2003 May 15;101(10):4078-87 - PubMed
  43. Nat Struct Mol Biol. 2014 Apr;21(4):336-45 - PubMed
  44. Cell. 2009 May 15;137(4):721-35 - PubMed
  45. Nat Med. 2001 Jun;7(6):680-6 - PubMed
  46. J Immunol. 2011 Feb 1;186(3):1564-74 - PubMed
  47. Br J Pharmacol. 2013 Aug;169(8):1723-44 - PubMed
  48. Carcinogenesis. 2007 Nov;28(11):2328-36 - PubMed
  49. J Biol Chem. 2018 Apr 13;293(15):5425-5430 - PubMed
  50. Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1466-71 - PubMed
  51. Oncotarget. 2017 Feb 7;8(6):9974-9985 - PubMed
  52. Methods Enzymol. 2000;322:325-45 - PubMed
  53. Methods Enzymol. 2017;588:79-108 - PubMed
  54. Cancer Res. 2007 Aug 1;67(15):7327-34 - PubMed
  55. Int J Mol Sci. 2019 Jul 20;20(14): - PubMed
  56. Cell Death Dis. 2013 Oct 10;4:e838 - PubMed
  57. Cells. 2019 Jan 30;8(2): - PubMed
  58. Semin Cancer Biol. 2020 Nov;66:3-11 - PubMed
  59. Nat Rev Cancer. 2017 May 24;17(6):352-366 - PubMed
  60. Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):19072-7 - PubMed
  61. Lancet. 2001 Jun 2;357(9270):1770 - PubMed
  62. Cell Commun Signal. 2020 Jan 27;18(1):12 - PubMed
  63. Immunity. 1995 Dec;3(6):673-82 - PubMed
  64. Acta Pharm Sin B. 2017 Jan;7(1):3-17 - PubMed
  65. Cell Death Differ. 2014 Dec;21(12):1852-61 - PubMed
  66. Nat Cell Biol. 2014 Jan;16(1):47-54 - PubMed
  67. Cancers (Basel). 2019 Dec 01;11(12): - PubMed
  68. Science. 2014 Jul 4;345(6192):98-101 - PubMed
  69. J Biol Chem. 2013 Nov 22;288(47):33654-33666 - PubMed
  70. J Biol Chem. 2012 Apr 6;287(15):12455-68 - PubMed

Publication Types

Grant support